Cutler Group’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Cutler Group’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-300	Closed	-$94K	–	3938
2023 Q4	$94K	Buy	+300	New	+$58.3K	0.01%	1085
2022 Q4	–	Sell	-825	Closed	-$185K	–	5464
2022 Q3	$185K	Buy	+825	New	+$167K	0.01%	1005
2021 Q1	–	Sell	-890	Closed	-$90K	–	6479
2020 Q4	$90K	Buy	890 +619	+228%	+$57.3K	﹤0.01%	1603
2020 Q3	$20K	Sell	271 -329	-55%	-$28K	﹤0.01%	2478
2020 Q2	$66K	Sell	600 -5,904	-91%	-$513K	﹤0.01%	1578
2020 Q1	$468K	Buy	+6,504	New	+$556K	0.02%	577

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Cutler Group's KRTX Position: Q1 2024 in Review

Cutler Group sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 300 shares — an estimated $94K sold.

Cutler Group first reported a position in KRTX in Q1 2020 and held it in 6 quarters. The position peaked at $468K in Q1 2020. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Cutler Group reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Cutler Group sold 300 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $94K.
Cutler Group first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2020 and held it in 6 quarters.
Cutler Group's Karuna Therapeutics, Inc. Common Stock position peaked at $468K in Q1 2020.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.